DUBLIN, Oct. 22, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/gbvjbb/brazil_medical) has announced the addition of the "Brazil Medical Devices Market, Magnetic Resonance Imaging & Defibrillator - Forecast to 2020" report to their offering.
The main companies operating in this Brazil medical devices market are GE Healthcare (U.K.), Philips Healthcare (Netherlands), Medtronic plc (U.S.), and Siemens Healthcare (Germany).
The report provides a detailed competitive landscaping of companies operating in this market. Segment and company shares, news & deals, M&As, segment-specific pipeline products, and product approvals, of the major companies have been detailed in the report.
The Brazil patient monitoring market is segmented into product and end user. Based on product, the market is sub segmented into hemodynamic, neuromonitoring, cardiac monitoring, respiratory, fetal and neonatal, multi-parameter, remote patient monitor, temperature monitor, and weight management monitor. The neuromonitoring devices market is expected to be the fastest-growing segment in the Brazil patient monitoring market during the forecast period.
The Brazil ultrasound market is segmented into technology, application, and product. Based on technology, the ultrasound market in Brazil is classified into diagnostic ultrasound and therapeutic ultrasound. The diagnostic ultrasound segment is expected to account for the largest share of the Brazil ultrasound market, by technology, in 2015. The increasing use of ultrasound technology for obstetrics and gynecological applications in the country is driving the market for this segment. The compact/handheld ultrasound devices segment is expected to grow at the highest rate during the forecast period. The increasing demand for compact and portable ultrasound devices is driving the market for these devices. By application, the cardiology segment is expected to be the fastest-growing market during the forecast period owing to the increasing incidence of cardiovascular disease in recent years.
The Brazil defibrillators market is segmented based on product and end users. By product, the market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The external defibrillators segment is expected to grow at the highest rate in forecast period. Technological advancements in these devices and the increasing number of public defibrillation programs are driving the market for external defibrillators.
The MRI market is segmented on the basis of architecture, field strength, and application. The closed MRI systems segment is expected to account for the largest share of the MRI systems market, by architecture. Based on field strength, high-field MRI systems are expected to account for the largest market share. The brain and neurological MRI application segment accounted for the largest share of the Brazil MRI systems market, by application, in 2015. The high clinical value of MRI in the early diagnosis of brain diseases and growing incidence of brain injuries & neurological disorders are the major drivers for the growth of the brain and neurological MRI segment.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Brazil Patient Monitoring Market
7 Brazil Magnetic Resonance Imaging (MRI) Market
8 Brazil Ultrasound Devices Market
9 Brazil Defibrillators Market
10 Competitive Landscape
11 Company Profiles
- Abbott Laboratories
- Boston Scientific Corporation
- GE Healthcare
- Hitachi Medical Corporation
- Medtronic PLC
- Mindray Medical International Limited
- Philips Healthcare
- Siemens Healthcare
- St. Jude Medical, Inc.
- Toshiba Medical Systems Corporation
For more information visit
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets